ASX:IMR Imricor Medical Systems (IMR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Imricor Medical Systems Stock (ASX:IMR) 30 days 90 days 365 days Advanced Chart Remove Ads Get IMR alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume27,486 shsAverage VolumeN/AMarket Capitalization$167.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewImricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.Read More… Remove Ads Receive IMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address IMR Stock News HeadlinesUp 200% in a year! Why is this ASX healthcare stock rocketing today?March 20, 2025 | msn.comImricor raises a whopping $70 million for growth in pivotal yearMarch 20, 2025 | msn.comYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.April 3, 2025 | Premier Gold Co (Ad)Imricor Medical Systems passes can around for $80m, Morgans on ticketMarch 16, 2025 | afr.comImricor hits key milestone in FDA approval process for ablation catheter devicesMarch 4, 2025 | msn.comImricor Medical Systems Reports Full Year 2024 EarningsMarch 1, 2025 | finance.yahoo.comImricor Medical Systems Inc (ASX:IMR) (FY 2024) Earnings Call Highlights: Regulatory Milestones ...February 27, 2025 | gurufocus.comFull Year 2024 Imricor Medical Systems Inc Earnings Call TranscriptFebruary 27, 2025 | gurufocus.comSee More Headlines IMR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Imricor Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imricor Medical Systems investors own include Frequency Therapeutics (FREQ), Cue Biopharma (CUE), Provention Bio (PRVB), Gold Standard Ventures (GSV), Nuwellis (CHFS), BCB Bancorp (BCBP) and Atomera (ATOM). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryPharmaceutical Products Current SymbolASX:IMR CIKN/A Webwww.imricor.com Phone952-818-8400FaxN/AEmployees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,260,000.00 Net Margins-2,458.31% Pretax MarginN/A Return on Equity266.83% Return on Assets-124.67% Debt Debt-to-Equity Ratio-146.38 Current Ratio1.46 Quick Ratio4.33 Sales & Book Value Annual Sales$867,996.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow25.56 Book ValueA($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares270,180,000Free FloatN/AMarket Cap$167.29 million OptionableNot Optionable Beta0.26 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (ASX:IMR) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imricor Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imricor Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.